Comparison |
Country of Origin |
United States | Unknown | Unknown | United States | United States |
For Use With |
For DxC 700AU® Analyzer | For BD Viper™ Instrument | For BD Viper™ Instrument | For use on the ACE Axcel and ACE Alera Clinical Chemistry Systems | For use on the ACE Axcel and ACE Alera Clinical Chemistry Systems |
Form |
Liquid | | | | |
Number of Tests |
| 1,152 Tests | 1,152 Tests | 450 Tests | 450 Tests |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Sample Type |
Whole Blood Sample | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Samples | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Samples | Serum / Plasma Sample | Serum / Plasma Sample |
Storage Requirements |
| | USP Controlled Room Temperature | Requires Refrigeration | Requires Refrigeration |
Test Method |
| Amplified DNA Assay | | | |
Test Name |
Everolimus | Chlamydia Trachomatis / Neisseria Gohorrhoeae (CT / NG) | Neisseria Gonorrhoea (NG) | Alanine Aminotransferase (ALT) | Aspartate Aminotransferase (AST) |
Test Type |
Immunosuppressant Immunoassay | Infectious Disease Immunoassay | DNA Amplification / Detection | Hepatic / General Chemistry | Hepatic / General Chemistry |
UNSPSC Code |
41116004 | 41116011 | 41116011 | 41116105 | 41116105 |
Volume |
R1: 1 X 22 mL, R2: 1 X 8 mL, Precipitation Reagent: 1 x 8 mL | 1,152 Tests | | | R1: 3 X 12 mL, R2: 3 X 12 mL |
Application |
Reagent Kit | Reagent Kit | Reagent Kit | Reagent Kit | Reagent Kit |
Features and Benefits |
|
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- For the quantitative determination of alanine aminotransferase activity in serum and lithium heparin plasma
|
- For the quantitative determination of aspartate aminotransferase activity in serum and lithium heparin plasma
|